Healthcare -
Biotechnology - NASDAQ - US
$ 0.91
9 %
$ 49.6 M
Market Cap
11.38
P/E
SPRO - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity SPRO - Spero Therapeutics, Inc.
182 M
LAST VALUE
3.25%
2 YEAR CAGR
7.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR